Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Maxwell John T.
SVP-Chief Financial Officer at Aquestive Therapeutics. Filing since 21 Nov 2018.
CIK 0001739025
Company
Date
Role
Action
Shares
Amount
Of holding
AQST
Aquestive Therapeutics, Inc.
18 Aug 2020
SVP-Chief Financial Officer
Sold, plan not stated
3,000
$24.00K
2.0%
AQST
Aquestive Therapeutics, Inc.
6 Dec 2018
SVP-Chief Financial Officer
Bought
5,000
$44.35K
3.4%
AQST
Aquestive Therapeutics, Inc.
21 Nov 2018
SVP-Chief Financial Officer
Bought
10,000
$98.00K
7.2%
3 decisions on file.
